Developing a Vision for Developing a Vision for Enhanced Foodborne - - PowerPoint PPT Presentation

Developing a Vision for Developing a Vision for Enhanced Foodborne‐Illness Source Attribution Information The Role of Product Tracing: t d d t today and tomorrow

Caitlin Hickey Jennifer McEntire Caitlin Hickey Institute of Food Technologists Jennifer McEntire Leavitt Partners

O i Overview

R l f P d t T i i O tb k

• Role of Product Tracing in Outbreak

Investigations

• IFT

FDA Product Tracing Pilots

• IFT – FDA Product Tracing Pilots

Outbreak Investigation Outb ea est gat o

• People get ill from something they ate
• Go to doctor?

Go to doctor?

• Doctor collects samples?
• Reported to public health?
• Samples further distinguished (molecular

techniques)

• Outbreak recognized

Outbreak recognized

• Go back to people and ask what they ate
• Try to find common product
• Try to find common source of the product –

convergence

• This is the regulatory traceback

g y

3

Traceability is not recall

Product Tracing Recall Conducted by regulators: Conducted by industry: y g balance making quick decisions with building a regulatory case y y protect public health and protect their firm and bottom line Implicated product not known – reliance on epi Specific product(s) known- Objective: identify points of Objective: remove product j y p convergence in supply chain to rule in/out suspects j p from the marketplace Relies on good Relies on good g recordkeeping by industry g recordkeeping by industry

5

F th l t ti hi hli ht From the last meeting highlights:

• “The scoping meetings are intended to provide a

platform for bringing together government and platform for bringing together government and industry representatives in the early stages of a foodborne illness outbreak investigation to share information and collaboratively develop a more information and collaboratively develop a more detailed analysis of the outbreak. The goals of these meetings are to provide CDC with critical g p information about food production and distribution….”

I T b k S l l “Aft th F t”? Is Traceback Solely “After the Fact”?

T d N

• Today: No
• Root cause analysis can help prevent future issues
• In the future: No
• In the future: No
• Can supply chain visibility help rule in/out certain

products/brands? p

• Instant, accurate knowledge of supply chains can help

inform epi

T b k T d Tracebacks Today

Oft ’t fi d i t f

• Often can’t find point of convergence
• Many reasons, to be studied by pilots
• Without convergence may not “definitively” know
• Without convergence, may not definitively know

the food

• = unsolved case
• = unsolved case
• = no food attribution

Pilot Requirements q

• Task issued to IFT Sept 6, 2011; final report

due June 6 due June 6

• Objective
• more rapidly and effectively trace back product

= greater likelihood of tying an outbreak to food

• 2 Pilots: Produce and Processed food

C ll b ti l tf

• Collaboration platform
• Cost/benefit evaluation

9

K Q ti Key Questions

Wh t d t ll d d t t d t ?

• What data are really needed to trace products?
• How can we ensure accuracy?

H GET it i kl ?

• How can we GET it quickly?
• How can we ANALYZE it quickly?

• Solicit Stakeholder input
• Products collaboration platform use of
• Products, collaboration platform, use of

existing systems, initiatives, cost data sources

• Baseline study- What is the process what makes it

Baseline study What is the process, what makes it

difficult/easier, where are the hang-ups

• Qualitative- discussions with traceback investigators
• Quantitative- evaluation of previous investigations
• Solicit participants
• Conduct tests
• Evaluate results and cost

11

T ti D t Testing Data

Lot/Batch Transfe r CTE Description Date Time Event Location Trading Partner Item /Serial Number Quantity Unit of Measure Order Number Order Type Numbe r Transfer Type Receiving

Accepting a shipment from another facility x x x x x x x x x x x x

g

y Changing the identity (such as a new item identifier description

Transformatio n

new item identifier , description, GTIN or batch identity) or characteristics (types of packaging, configuration of contents, etc) of a product

T1

Items input into a transformation

T1

process x x x x x x x x x x

T2

Items output from a transformation process x x x x x x x x x Releasing product from one

Shipping

Releasing product from one facility to another x x x x x x x x x x x x

Evaluate results based on

• Evaluate results based on
• Speed to convergence/resolution
• Mapping speed of analysis to practices (current state)
• Mapping speed of analysis to practices (current state)
• Assessing speed of analysis when industry uses a

template

• Evaluation of collaboration platforms
• Speed

A

• Accuracy

13

After Report Completion p p

• FDA report to

Congress- early July

• IFT intends to publish

report report

• FDA must have 3

public meetings public meetings

• Rulemaking process

14

Questions?

CHickey@ift.org

To Stay Current Subscribe to Leavitt Partners Newsletter.

Text your email to: 801‐891‐3451

http://www.ift.org/traceability